title: Depressive symptoms during buprenorphine treatment of opioid abusers.
abstract: Among 40 opioid addicts treated as outpatients with sublingual buprenorphine (2-8 mg daily) for a month, depressive symptoms significantly decreased in the 19 who were depressed at intake to treatment.
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, CT.
authors.forename: T R
authors.initials: TR
authors.lastname: Kosten
authors.forename: C
authors.initials: C
authors.lastname: Morgan
authors.forename: T A
authors.initials: TA
authors.lastname: Kosten
mesh_terms: D000328:Adult; D002047:Buprenorphine / Q000627:therapeutic use*; D003042:Cocaine; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000523:psychology / Q000534:rehabilitation*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000523:psychology / Q000534:rehabilitation*; D010556:Personality Tests; D019966:Substance-Related Disorders / Q000534:rehabilitation
chemical_list: D002047:Buprenorphine; D003042:Cocaine; D008691:Methadone